| Literature DB >> 33081749 |
Lanchu Yu1, Qin Jiao1, Yu Cheng1, Yanji Zhu1, Zhongjing Lin2, Xi Shen3.
Abstract
BACKGROUND: To investigate the difference in retinal nerve fiber layer (RNFL) thickness, choroidal thickness (CT) and superficial retinal vessels between thyroid-associated ophthalmopathy (TAO) patients and healthy controls. To identify the potential influencing factors for these parameters and evaluate their diagnostic abilities in TAO.Entities:
Keywords: Choroidal thickness; Optical coherence tomography angiography; Retinal nerve fiber layer; Thyroid-associated ophthalmopathy
Mesh:
Year: 2020 PMID: 33081749 PMCID: PMC7576755 DOI: 10.1186/s12886-020-01692-7
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Fig. 1The 3 × 3 mm optical coherence tomography angiography image of the macular region of the retina (a) OCTA image showing the detailed structure of superficial retinal vessels (b) OCTA image showing the FAZ area (c) OCTA image showing the measurement of vascular density in the macular region (d) OCTA image showing the measurement of perfusion density in the macular region
The basic characteristics of the study population
| Active TAO | Inactive TAO | Normal | ||
|---|---|---|---|---|
| Age (years) | 43.5 ± 11.5 | 39.3 ± 11.3 | 38.7 ± 12.5 | 0.339 |
| Sex (F/M) | 12/8 | 27/6 | 24/5 | 0.121 |
| Proptosis (mm) | 21 ± 3 | 18 ± 3 | 16 ± 2 | < 0.001 |
| IOP (mmHg) | 22.6 ± 4.3 | 16.5 ± 3.3 | 15.4 ± 2.6 | < 0.001 |
| AL (mm) | 23.53 ± 1.28 | 24.08 ± 1.01 | 24.20 ± 1.08 | 0.100 |
| CCT (μm) | 541 ± 27 | 540 ± 27 | 534 ± 30 | 0.633 |
OCT analysis results in different study groups (μm)
| Active TAO | Inactive TAO | Normal | P1 | P2 | P3 | ||
|---|---|---|---|---|---|---|---|
| Average | 92 ± 7 | 101 ± 8 | 102 ± 8 | < 0.001 | < 0.001 | < 0.001 | 0.999 |
| Superior | 116 ± 15 | 121 ± 18 | 122 ± 16 | 0.458 | |||
| Temporal | 72 ± 10 | 84 ± 13 | 83 ± 13 | 0.001 | 0.002 | 0.004 | 0.991 |
| Inferior | 117 ± 11 | 133 ± 16 | 132 ± 15 | 0.001 | 0.001 | 0.004 | 0.932 |
| Nasal | 63 ± 7 | 68 ± 10 | 67 ± 9 | 0.117 | |||
| Average | 257 ± 37 | 260 ± 42 | 218 ± 32 | < 0.001 | 0.795 | < 0.001 | < 0.001 |
| Subfoveal | 304 ± 41 | 299 ± 45 | 258 ± 38 | < 0.001 | 0.676 | < 0.001 | < 0.001 |
| Superior | 270 ± 33 | 274 ± 42 | 216 ± 30 | < 0.001 | 0.753 | < 0.001 | < 0.001 |
| Temporal | 261 ± 42 | 265 ± 41 | 223 ± 38 | < 0.001 | 0.752 | 0.002 | < 0.001 |
| Inferior | 251 ± 36 | 264 ± 41 | 216 ± 30 | < 0.001 | 0.193 | 0.001 | < 0.001 |
| Nasal | 235 ± 50 | 241 ± 45 | 203 ± 38 | 0.004 | 0.655 | 0.016 | 0.001 |
P1: P value for the comparison group between active TAO and inactive TAO
P2: P value for the comparison group between active TAO and normal controls
P3: P value for the comparison group between inactive TAO and normal controls
OCTA analysis results in different study groups
| Active TAO | Inactive TAO | Normal | P1 | P2 | P3 | ||
|---|---|---|---|---|---|---|---|
| 0.36 ± 0.09 | 0.31 ± 0.08 | 0.28 ± 0.08 | 0.006 | 0.045 | 0.001 | 0.130 | |
| Superior | 21.1 ± 1.5 | 22.0 ± 1.1 | 21.4 ± 1.8 | 0.063 | |||
| Temporal | 20.3 ± 1.6 | 21.5 ± 1.1 | 20.7 ± 2.1 | 0.026 | 0.012 | 0.485 | 0.044 |
| Inferior | 21.0 ± 1.4 | 21.9 ± 1.3 | 20.6 ± 1.8 | 0.004 | 0.027 | 0.481 | 0.001 |
| Nasal | 21.2 ± 1.4 | 22.0 ± 1.2 | 21.5 ± 1.9 | 0.148 | |||
| Average | 21.0 ± 1.1 | 21.9 ± 0.9 | 21.0 ± 1.7 | 0.005 | 0.003 | 0.691 | 0.014 |
| Superior | 0.380 ± 0.029 | 0.393 ± 0.021 | 0.381 ± 0.031 | 0.097 | |||
| Temporal | 0.367 ± 0.030 | 0.386 ± 0.020 | 0.368 ± 0.041 | 0.045 | 0.016 | 0.508 | 0.092 |
| Inferior | 0.378 ± 0.025 | 0.387 ± 0.028 | 0.360 ± 0.028 | 0.001 | 0.222 | 0.025 | < 0.001 |
| Nasal | 0.384 ± 0.034 | 0.390 ± 0.022 | 0.385 ± 0.027 | 0.619 | |||
| Average | 0.382 ± 0.033 | 0.389 ± 0.016 | 0.372 ± 0.026 | 0.032 | 0.309 | 0.181 | 0.009 |
P1: P value for the comparison group between active TAO and inactive TAO
P2: P value for the comparison group between active TAO and normal controls
P3: P value for the comparison group between inactive TAO and normal controls
Associations between OCTA parameters and clinical variables
| FAZ area | Average vascular density | Average perfusion density | ||||
|---|---|---|---|---|---|---|
| r | r | r | ||||
| Age | 0.136 | 0.224 | −0.114 | 0.308 | −0.076 | 0.500 |
| Proptosis | 0.152 | 0.173 | 0.051 | 0.652 | 0.122 | 0.276 |
| IOP | 0.274 | 0.013* | 0.008 | 0.994 | 0.195 | 0.079 |
| AL | −0.344 | 0.002* | 0.118 | 0.292 | 0.025 | 0.821 |
| CCT | 0.093 | 0.406 | −0.010 | 0.927 | −0.057 | 0.610 |
| Average RNFL | −0.070 | 0.531 | 0.169 | 0.129 | 0.113 | 0.312 |
| Average CT | 0.124 | 0.267 | 0.043 | 0.700 | 0.184 | 0.099 |
* indicated significant difference with P < 0.05
Area under curve with 95% confidence interval in different subgroups
| Active TAO/inactive TAO | Active TAO /Normal | Inactive TAO /Normal | ||||
|---|---|---|---|---|---|---|
| AUC (95%CI) | AUC (95%CI) | AUC (95%CI) | ||||
| RNFL thickness | 0.804 (0.704,0.904) | < 0.001 | 0.818 (0.701,0.935) | < 0.001 | 0.514 (0.368,0.660) | 0.849 |
| Choroidal thickness | 0.569 (0.424,0.714) | 0.353 | 0.814 (0.693,0.935) | < 0.001 | 0.828 (0.719,0.936) | < 0.001 |
| FAZ area | 0.617 (0.468,0.766) | 0.117 | 0.711 (0.564,0.858) | 0.013 | 0.595 (0.453,0.737) | 0.202 |
| Vascular density | 0.743 (0.610,0.877) | 0.001 | 0.534 (0.371,0.696) | 0.692 | 0.682 (0.544,0.821) | 0.014 |
| Perfusion density | 0.663 (0.506,0.820) | 0.029 | 0.533 (0.367,0.699) | 0.699 | 0.699 (0.565,0.833) | 0.007 |
Sensitivity and specificity of different parameters in different subgroups
| active TAO/inactive TAO | active TAO/normal | inactive TAO/normal | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Cut-off | Sen | Spe | Cut-off | Sen | Spe | Cut-off | Sen | Spe | |
| RNFL thickness | 99 | 0.667 | 0.850 | 98 | 0.724 | 0.800 | 103 | 0.485 | 0.621 |
| Choroidal thickness | 258 | 0.545 | 0.700 | 250 | 0.103 | 0.400 | 241 | 0.848 | 0.759 |
| FAZ area | 0.28 | 0.758 | 0.300 | 0.35 | 0.172 | 0.500 | 0.35 | 0.364 | 0.828 |
| Vascular density | 21.6 | 0.697 | 0.800 | 21.6 | 0.345 | 0.800 | 21.6 | 0.697 | 0.655 |
| Perfusion density | 0.381 | 0.697 | 0.700 | 0.381 | 0.483 | 0.700 | 0.376 | 0.848 | 0.517 |
Sen Sensitivity, Spe Specificity
Fig. 2ROC curves for different parameters to discriminate active TAO from inactive TAO eyes
Fig. 3ROC curves for different parameters to discriminate active TAO from normal eyes
Fig. 4ROC curves for different parameters to discriminate inactive TAO from normal eyes